Abstract | Implantable neuroprostheses are engineered systems designed to restore or substitute function for individuals with neurological deficits or disabilities. These systems involve at least one uni-or bidirectional interface between a living neural tissue and a synthetic structure, through which information in the form of electrons, ions or photons flows. Despite a few notable exceptions, the clinical dissemination of implantable neuroprostheses remains limited, because many implants display inconsistent long-term stability and performance, and are ultimately rejected by the body. Intensive research is currently being conducted to untangle the complex interplay of failure mechanisms. In this Review, we emphasize the importance of minimizing the physical and mechanical mismatch between neural tissues and implantable interfaces. We explore possible materials solutions to design and manufacture neurointegrated prostheses, and outline their immense therapeutic potential.
Ageing, trauma and neurodegenerative diseases lead to cognitive, behavioural and sensorimotor deficits that affect the quality of life of millions of people worldwide. Implantable neuroprostheses provide solutions to alleviate many of the symptoms associated with these conditions. For example, cochlear implants restore hearing in people suffering from profound hearing loss; deep brain stimulation alleviates Parkinsonian symptoms; spinal cord stimulators help manage neuropathic pain; and vagal nerve neuromodulation mitigates depression. Considering the number of patients who could benefit from these technologies, their dissemination remains limited and their potential remains comparatively underexploited. For example, paralysed individuals have been able to control a sophisticated robotic arm or their own forearm muscles using brain signals only 1, 2 . However, the recorded neural signals extinguish rapidly 3 , which currently restricts the clinical potential of these implantable brain-machine interfaces 4 . Historically, the biocompatibility of a neural implant has been mostly quantified in terms of chemical and electrochemical stability, and toxicity. However, tissueimplant interactions are triggered by very different phenomena, such as insertion trauma, neuroglial activation, cell migration and blood-brain barrier breakdown, that occur in concert and at multiple time points. In this Review, we explore one of these critical interactions that impedes the deployment of existing and contemplated implantable neuroprostheses: the physical and mechanical mismatch between man-made implants and the targeted neural tissues. Cells and neural tissues are several orders of magnitude softer than the materials used in neural implants. Cells respond to the mechanical properties of the surfaces they are in contact with. In vitro, environments with adjustable stiffness show that cells alter their motility, shape, differentiation outcome, activation and general function on the basis of the compliance and topography of their surroundings. In vivo, the soft neural tissues display viscoelastic properties that are often anisotropic, withstand uninterrupted motion due to blood flow, respiratory pressure and natural body movements, and undergo changes in volume throughout life. By contrast, most neural implants are rigid and static. For example, clinical implants are often prepared with platinum-iridium electrodes and stainless-steel wires embedded in silicone to form flexible, millimetrethick electrode paddles [5] [6] [7] . They may be machined with a built-in curvature to provide consistent electrode contact with the neural tissue. Such design is suitable for neurostimulation devices that require large electrode contacts over the surface of the brain or spinal cord. However, this type of technology fails to provide the resolution and stability that is necessary for long-term recordings of neural signals owing to the substantial distance between the electrode and targeted neurons. Implantable electrodes prepared in both academic environ ments and commercial research and development are prepared from a broader palette of materials borrowed from microelectronics, and biomedical and regenerative technologies. In the past decade, advances in soft bioelectronics -mechanically compliant electronics customized to interface biological tissues -have enabled novel strategies to remedy the issues of physical and mechanical mismatch and to restart the design process of implantable neuroprostheses [8] [9] [10] . Here, we review recent strategies to design, manufacture and implement soft implantable neuroprostheses with improved biointegration and enhanced functionalities. We describe the shape, surface topology and biomechanics of neural tissues across mammalian species, and translate these physiological properties into design guidelines to construct physically matched synthetic implants. We provide examples of recent implantable neuroprotheses that have achieved superior neurointegration through designs, materials or technologies that obeyed at least one aspect of these guidelines. We conclude in discussing the enticing potential of soft implantable neuroprostheses to replace and restore neural functions after trauma and neurological disorders.
Understanding neural materials Macroscopic and morphological considerations
The mammalian central nervous system (CNS) is arguably the most complex biological organ. The CNS is composed of the brain and spinal cord, which send and receive signals to and from the rest of the body via the peripheral nervous system (PNS). Despite its peripheral location, the retina is also part of the CNS. The size and topography of the brain display remarkable differences across mammalian species (FIG. 1a) . The adult human brain weighs approximately 1.5 kg (REF. 11 ) and the surface of the cerebral cortex is greater than 2,500 cm 2 . The brains of the main animal models used in neuroprosthetic research pale in comparison. For example, the weight of the brain and surface area of the cerebral cortex range from 1.8 g and 6 cm 2 for the adult rat 12 to 90 g and 110 cm 2 for the rhesus monkey 13 . The topologies of the brain also differ widely: small mammals have smooth brain surfaces, whereas the brains of primates (including humans) display complex external topographies and patterns of convolution that result from gyrification of the cortical surface 14 (FIG. 1a) . Gyrification refers to the cortical folding that gives the brain its wrinkle-like appearance with ridges (gyri) and grooves (sulci) 15 . The cerebral cortex of humans -the outer, 2-3-mm-thick layer of grey matter over the brain hemispheres -is a highly convoluted structure, with more than half of its actual surface area hidden from the apparent, directly accessible outer brain surface. Typical sulci radii and gyri depths in the cortex of primates 13 are in the range of 1-5 mm. In the CNS, the cerebral and spinal tissues are protected by a multi-layered structure formed of meninges (that is, membranes including the pia mater, arachnoid mater and dura mater), bone, connective tissue and skin (FIG. 1b,c) . In the PNS, longitudinal axon bundles are grouped in fascicles protected by the perineurium, which in turn may be bundled together with blood supply and fatty tissue within another sheath, the epineurium (FIG. 1d) . Each of these membranes has a key mechanical role in protecting the delicate neural tissues and mitigating their dynamic response, not only to physiological movement and pressure changes in the cerebrospinal fluid, but also to injury.
Neural tissues withstand constant mechanical activity. The brain is a pulsatile organ submerged in cerebro spinal fluid and regulated by cardiac cycles and respiration. Adequate blood flow to the brain is crucial for maintaining normal brain function. Because the brain is enclosed in the rigid skull, pressure and flow pulsations are transferred to the soft brain tissue (resulting in local motion on a micrometre scale), arterial and venous network, and cerebrospinal fluid 16 . In freely behaving mammals, ventroflexion (that is, bending forward) causes tensile elongation of the spinal cord tissue accompanied with Poisson compression, whereas extension (that is, bending backwards) causes wrinkling of soft tissues inside the spinal canal. In humans, both the spinal cord and its meningeal protective membranes can experience as much as 10-20% tensile strain and displacement (relative to the spinal canal) during normal postural movements. This motion corresponds to displacements on the order of centimetres 17 . The deformations relative to the spinal cord in animal models, such as rodents or non-human primates, are likely to be even larger.
The mechanical properties of the dura mater and the nerve epineurium and perineurium are especially relevant for neural implants, because most interfaces lie immediately above or below this protective membrane or must pierce through it in order to access the neural tissue. The dura mater consists of collagen fibres that are interdispersed with fibroblasts and elastin and is traversed by a network of blood vessels. In humans, its thickness varies from 0.3 to 0.8 mm, depending on the age of the individual 18, 19 . Both cranial and spinal dura maters exhibit hyperelastic and viscoelastic stress-strain behaviour, typical of collagenous tissues, with an elastic modulus of 0.5-1.2 MPa (REF. 20 ). Their toughness also prevents the insertion of brittle electrodes through the dura mater without performing a surgical incision of the meninges and/or the use of guide tubes or cannulas.
Peripheral nerves are anisotropic structures that spread throughout the body. They vary significantly in diameter; for example, the small visceral nerves are about 100 times smaller than the sciatic nerve, which reaches up to 2 cm in diameter in humans. Nerve epineurium and perineurium are formed of bundles of collagen fibres and elastin 21 . When tension is applied to a nerve, its initial undulated resting shape accommodates some elongation without generating appreciable stress along the fascicles and axons. The elasticity of the connective tissue surrounding a nerve helps preserve the integrity of the axon. As the tensile loading increases, the nerve displays quasi-elastic stress-strain behaviour until rupture of the perineurial sheath, which occurs with a fracture strain of ~25% and an ultimate stress of ~10 MPa. Nerve fibres start to rupture in the endoneurium sheath at lower strains 21 .
Cellular considerations
The brain and spinal cord host different kinds of neurons and several types of glial cells, which interact in many intricate and mutually supporting ways to enable the overall functional performance of the neural tissue. The stereotypic nerve cell presents a cell body (soma) and between 1 and about 1,000 dendrites, which receive signals via synapses from other nerve cells. After integration and processing of this external information, action potentials propagate towards other cells via a single, long process called the axon. The axon is a few micrometres thick, but can reach up to a metre in length. The network of neuronal processes conveys a considerable amount of mechanical connectivity throughout the tissue. The function of the various glial cell types is to support and modulate the performance of the neurons. Oligodendrocytes (similar to Schwann cells in the PNS) produce thin and wide insulating myelin sheaths wrapped around each axon. These cells primarily support the transport of information along the axon, but also offer additional mechanical connectivity to the tissue. Astrocytes provide general biochemical support to other cells and modulate the information processing at synapses. They also contribute to the repair of tissue after injury and the formation of scars that protect the neural environment from the rest of the body. Microglia are the resident immune cells of the CNS, which also initiate and mediate the foreign body reaction (FBR) against foreign material, such as implants, introduced into the CNS 22 . The material properties of these cellular tissue constituents contribute to the stiffness of the entire tissue. Their intrinsic properties have been investigated 23, 24 after isolation from the tissue. Neurons, isolated from neo natal rat cortex, guinea-pig hippocampus and retina, have been probed with atomic force microscope (AFM)-based nano-indentation, which revealed rate-dependent, nonlinear viscoelastic behaviour with shear moduli between a few tens to a few hundred pascals [25] [26] [27] . In these studies, it was found that under lateral compression, neuronal and glial processes were softer than their somata 26 . However, a more recent study using magnetic tweezers for local rheological measurements revealed that the soma is softer and more solid-like compared with the stiff and viscous-like neurites. The authors concluded that axons are probably more sensitive to mechanical damage than the soma 28 . However, the main load-bearing direction of neural processes is actually oriented along their length, in which elastic spring constants of a few hundred mN m −1 , viscoelastic relaxation and also active contraction have been observed [29] [30] [31] [32] [33] [34] . It is noteworthy that processes of neurons in the CNS display lower spring constants than those of neurons in the PNS 8, [22] [23] [24] . In contrast to many other cell types, glial cells are roughly as compliant as neurons with Young's moduli on the order of ten to a few hundred pascals 26, 35, 36 . Relevant in the context of the FBR against implants is that cell stiffness can change when cells are activated. For example, acutely isolated Müller glial cells from an ischemic retina are stiffer than the cells from a healthy retina. This increased stiffness is attributable to an increase in the density of intermediate filaments such as glial fibrillary acidic protein (GFAP) and vimentin 36 . By contrast, cultured primary astrocytes soften considerably following either interferon-β (IFNβ) stimulation 37 or a stretch-induced upregulation of GFAP 38 . To our knowledge, no information on microglial stiffness has been reported so far, which is probably because of the phagocytic activity of these cells when they are in contact with a measurement probe.
Tissue considerations
The extracellular matrix (ECM) is embedded in the interstitial space between the cell bodies and their processes. The ECM consists of fibrous proteins, proteoglycans and glycosaminoglycans, such as laminin and hyaluronan. In the CNS, these elements form a dense mesh [39] [40] [41] [42] with a striking scarcity of collagen, which is the dominant ECM component elsewhere in the body 43 . In the adult human CNS, the total volume fraction of the ECM is about 20% 44 . For a recent review of the regional distribution of these ECM components and the corresponding cell adhesion molecules in the CNS, see REF. 45 . In addition to their direct biological function, the ECM molecules maintain adhesion between cells and thus provide additional mechanical resistance to the deformation of the entire tissue.
How these components -cells and the ECMcontribute to the overall mechanical properties of the CNS tissue is still poorly understood. Their relative importance is probably inverted compared to that of most other soft tissue in the body, for which the stiffness is largely dominated by a polymer matrix formed of collagen with the interstitial cells having less importance. Consequently, both collagen gels reconstituted in vitro and most body tissues display strain stiffening and compressive softening. Brain (and fat) tissue exhibits the opposite mechanical behaviour: it stiffens under compression but softens with strain 46 . This behaviour is consistent with the picture of the brain as largely a dense colloidal system (in which the cell bodies are the colloids) connected by an adhesive mesh of ECM, direct cell-cell contacts and connections via cell processes (for example, dendrite, axon and glial processes). The overall CNS stiffness is comparable to that of individual cells and, for example, in the brainstem, axons have been shown to be stiffer than the surrounding ECM 47 . Further, as previously mentioned, collagen is absent from the ECM of the brain, which only takes about 20% of the volume and thus is unlikely to have a large load-bearing role. Both neural cells and ECM are nonlinear mechanical entities that can alter their properties under isotropic pressure and anisotropic tension or compression 48 . In addition, pH and ions in the interstitial liquid, together with their interplay with the highly charged and sulfated ECM components, contribute osmotic and additional charge effects 49 . Despite the current lack of a comprehensive, bottomup model of the mechanical properties of CNS tissue, there is no scarcity of experimental reports on the mechanical properties of brain, spinal cord and retina, both in vivo and in vitro, and at spatial scales from organ to cell. Since the first measurements in the 1960s 50, 51 , there are now several excellent reviews covering the wide spectrum of work conducted on this topic 23, 48, 49, 52 . For the bulk brain, typical elastic moduli reported range from a few 100 Pa to about 10 kPa in oscillatory shear rheological measurements in vitro, depending on strain, shear rate, preconditioning and several other factors 48 . This also holds for the spinal cord 48, 53 and retina 54 . On a smaller scale, depending on the region of the CNS, different types, spatial orientations and relative numbers of neurons, glial cells and their processes, as well as different amounts of ECM, contribute to the mechanical properties measured 53, [55] [56] [57] [58] [59] . For example, grey matter regions in the cerebellum, consisting mainly of cell bodies, tend to be stiffer (Young's modulus measured with AFM, E ≈ 450 Pa) than white matter regions (E ≈ 300 Pa), which essentially contain many axonal tracts 60 . A similar result has been reported for the rat spinal cord measured with AFM, further demonstrating the greater anisotropy of white matter 53 . Even on a larger scale, this result seems to hold 61 . The difference between white and grey matter might stem from the lower cell density in the former 53 , which is structurally dependent on the oligodendrocyte connectivity, because demyelination in the rat spinal cord leads to lower stiffness and tensile stress 62 . Lower stiffness has also been reported for demyelinated regions in the murine brain parenchyma measured with magnetic resonance elastography (MRE) 63 . Although this seems to form a clear picture, it should be noted that there are also reports of white matter being 40% stiffer, and more viscous, than grey matter 55 .
Age can also have a role, with older brains tending to be stiffer 64 . By contrast, MRE shows fluidization with age (and that female brains are more elastic than male brains) 65 . Such discrepancies are not uncommon in this field and are widely discussed 22, 47, 51, 65, 66 . They could emanate from different preparative procedures of the tissue, time and length scales, as well as modes of deformation, and the change of properties between in vivo and in vitro measurements, among other possible factors. Improved microscopic models of brain tissue might help to resolve these differences in the future 49, 66 .
Important features for neural implant design
Given the uncertainties discussed in the previous subsections, what are the reliable features and what do we need to consider in the design of neural implants? One important parameter is the compliance of the neural tissue, quantified by its Young's modulus and reported in the range of 100 Pa to 10 kPa for CNS tissue. In contrast to other biological tissues, the high compliance of the CNS tissue is independent of species, age and regions within the CNS. Another important feature to consider when evaluating materials properties for the design of future implants is the size. Indeed, tissue stiffness values strongly depend on the probing technique, associated probe format and rate at which the tissue is strained. For example, the lowest values of about 100 Pa obtained by AFM 53, 57, 60, 64 for the CNS modulus are probably due to tissue constituents, and importantly water, being able to accommodate and flow around the micrometre-sized, indenting probe. On scales much larger than that of the tissue constituents, or in tensile probing, the incompressibility of water will probably contribute a much greater resistance to motion and thus yield a higher elastic modulus 67 . Consequently, it could be possible for large implants to be kept stiffer (on the order of 10 kPa) than implants with fine features on a cellular scale, such as thin meshes or micrometre-scale wires.
A third parameter to consider is the mechanical contrast between the pulsating neural tissue and the static implant. The recurrent motion of the surrounding tissue with respect to implants will cause different kinds of damage, depending on the physical properties of the implant 68 . The insertion of the implant into the brain also alters the mechanical properties of the surrounding tissue itself. After the implantation of microelectrodes, brain tissue exhibits appreciable stiffening during the first four weeks after implementation owing to the formation of a stiff matrix surrounding the implant. This matrix gradually softens and the stiffness eventually returns to its original value (that is, before implantation) 68 . A more extreme example is the effect of a lesion on neural tissue. For example, the hemisection of a rat spinal cord leads to a decrease of the elastic modulus but an increase of the viscosity, measured by micro-indentation 2 and 8 weeks after injury 69 . The development of most neural implants is conducted in mammalian animal models. Therefore, the similarities and differences in the mechanics, morphology and size of relevant tissues between the most common animal models and humans must be taken into consideration. In a study 70 (FIG. 1a) . Other CNS features and macroscopic curvatures exhibit similar differences in scale among species. These differences pose design considerations in terms of the bending stiffness (thickness) of implants when scaling up from small animal models to implants for use in humans. This is especially true when implant conformity to the increasingly undulated brain surfaces from mouse to primate brains is important. We are still far away from a having a thorough understanding of the complex and intricate mechanical properties of CNS tissue, which itself is an interesting frontier of materials research. However, we probably know enough to start tailoring implants that match the mechanics of the brain. In the following section, we highlight recent technological efforts geared towards implementing mechanical compliance in synthetic materials and implants.
The soft neurotechnology toolbox Today, there is no worldwide consensus on the most appropriate implantable materials for neural interfaces. Platinum-iridium, titanium, stainless steel and silicones are widely used in clinical devices following stringent and local standards regulated, for example, by the International Organization for Standardization (ISO) in Europe, the US Food and Drug Administration (FDA) and the Ministry of Health, Labour and Welfare (MHLW) in Japan. It is also important to consider that an approved material in its bulk form may no longer be biocompatible once transformed, processed and/or used in a neural implant. New materials and assembly techniques are not systematically discarded because of biosafety or biocompatibility standards, but their validation and approval may be long and laborious.
Considering electrode-tissue mechanical interactions, nearly all implantable electrodes, whether clinically approved or under development, are stiff with a mismatch in elastic moduli of several orders of magnitude compared with the targeted neural tissue (FIG. 2) . Their insertion into living neural tissues triggers bidirectional interactions (that is, both implant-to-tissue and tissue-to-implant responses). Man-made implants induce insertion-related trauma to the host biological tissues, acute and then chronic inflammation, gliosis and disruption of the blood-brain barrier 71 . Conversely, the active and reactive biological medium affects the synthetic devices. These alterations include structural degradation 5 , material corrosion, insulating material failure 4 and electrode impedance fluctuation 6 over periods of weeks to months. These changes compromise the stability and capability of recording or stimulating neural signals. Recent efforts in smart materials and soft bio electronics aim at tackling the multiscale, multifunction mismatches between neural tissues and man-made implants. The majority of these approaches involve the design of flexible mechanical structures [7] [8] [9] , the engineering of elasticity in a stiff and rigid material [7] [8] [9] and the integration of softer materials into implants 20, 72 . Two main objectives are being jointly pursued with the 'soft neurotechnology' toolbox: minimizing the long-term FBR and implementing multiple recording and neuromodulation modalities in mechanically compliant structures.
Reduced foreign body reaction
The surgical insertion of a synthetic device in the vicinity of or into a neural tissue triggers an immediate FBR that continues throughout the in vivo lifetime of the neural implant. This acute inflammation will turn into a chronic neuroinflammatory response characterized by a complex interplay of molecular and cellular components. 
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Mechanical stiffness of conformal surface implants.
The physical and material properties of the implant, as well as the site of implantation, affect the intensity and duration of inflammatory and healing processes. Static and rigid implants fail to accompany the natural microand/or macroscopic motion of the neural tissues. Several groups have now demonstrated that the mechanical differences between neural tissues and implant materials induce adverse strain fields in the immediate vicinity of the device, which may lead to irreversible tissue damage and electrode failure 4, 71, 73, 74 . Surface implants should conform as much as possible to the convoluted surface of the brain (FIG. 3) , spinal cord or peripheral nerves (FIG. 4) . Implant (macroscopic) compliance may be achieved through the use of ultrathin materials. The flexural stiffness, D, of a material is defined in equation 1: the thinner the material, the more bendable it is 75 .
where E is the elastic modulus, h is the thickness of the material and ν is Poisson's ratio. For example, the use of ultrathin and flexible electrodes combined with micrometre-thick silicon transistor membranes has enabled recordings of electrocorticograms (EcoG) from inaccessible cortical areas such as the interhemispheric fissure 76, 77 . To accommodate the dynamics of the neural tissue, the tensile stiffness of the implant is another crucial design parameter. The tensile stiffness determines the ability of the implant to reversibly expand and relax with the underlying tissue. Patterning extremely thin (<10 μm) and stiff films into web-like systems improves the mechanical coupling between the implant and the underlying moving tissue. On mechanical loading, the mesh develops into 3D out-of-plane structures with engineered compliance. These 3D topologies have been exploited to fabricate stretchable metallic conductors 78 that conform to the curved surface of the skin 79 and biological organs 9, 80 . A transient packaging material (for example, silk) is usually added to coat the delicate open-mesh surface and to ease handling and surgical insertion 76 . However, the dimensions of the mesh ligaments should be carefully controlled. Indeed, even in a thin and narrow rectangular format, the stiff and non-elastic mat erial may severely limit the motion of the underlying neural tissue, or debond and slide against it, which is likely to induce and exacerbate damage and neuroinflammation. 
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An alternative approach involves the manufacturing of the implant with elastic materials that render it soft and stretchable. When designed in a solid membrane format, this type of soft implant presents several advantages over thin films. First, the membrane is robust, which facilitates the handling of the implant and its surgical insertion into intricate regions of the CNS. For example, these membranes have been implanted chronically below the dura mater of the brain and spinal cord in rats. Second, these soft implants do not trigger the FBR. Indeed, a soft implant inserted subdurally prepared as a macroscopic membrane of elastomers with tensile mechanics matching that of dura mater 20, 81 proved nearly imperceptible to the underlying tissue even after weeks of implantation (FIG. 5a,b) . This immediate and long-lasting biointegration is especially promising for ECoG arrays, which are typically used to monitor neural activity from the cortical surface.
Bioresorbable implants, prepared with ultrathin implantable electrode technology, also promise improved biointegration in acute and short-term transient neural interfaces. The nanometre-thick materials embedded in thin resorbable substrates yield devices with levels of mechanical flexibility necessary for conformal contact and stable interfaces with neural tissues for a preset duration 82, 83 .
Mechanical coupling of penetrating electrodes.
The physical coupling between penetrating electrodes and neural tissues is even more complex given the trauma, local inflammation and astroglial scarring around the implant. Combinatorial strategies ranging from molecular biology to engineering are needed to design and implement long-term 'stealth' and functional implants. Here, we focus on the importance of the mechanical coupling between the implant and the tissue. A more exhaustive review on the various factors at work may be found in REF. 7 .
Macroscopically, the implant should be mechanically decoupled from (but electrically communicating with) its anchoring point, which is usually in the surrounding bone via a flexible electronic cable. This decoupling allows the probe to move with the neural tissue 1, 20 . The mechanical response of the neural tissue to the insertion of a penetrating implant is influenced by the geometry of the probe and the speed at which the probe is inserted. Rapid insertion of sharp implants 84 (>1 mm s −1
) made of stiff materials, such as silicon, is often favoured, because clean transection of fibres and cell membranes results in less distortion or tearing of neurons and vascular damage 85 . A low insertion speed (<200 μm s −1 ) may, however, better account for the viscoelastic response of the brain and provide time for displaced capillaries and fibres to recover without rupture 85 . Buckling of the soft implant during the surgical insertion is an important parameter that must be accounted for. Intuitively, small cross-section probes made of soft materials will easily bend at the surface of the tissue. Several strategies have been proposed to facilitate the insertion of soft implants. These strategies include the use of insertion aides 86 , dissolvable, rigid carriers 87 , stiffening of the implant backbone 88 and larger designs (>1-mm 2 cross-section). An interesting alternative is the implementation of mechanically adaptable materials: that is, engineered polymers that soften once in vivo. Such materials have been implemented in a range of biomedical applications and have only recently been explored for neural interfaces. In situ softening may be produced with shape-memory polymers 89 or smart nanocomposites 90 . A biomimetic approach inspired by the structure of the dermis of the sea cucumber led to a mechanically adaptive material that can switch from a stiff and dry form (with a GPa-range Young's modulus) to a soft matrix (with a MPa-range Young's modulus) after a 10-20-minute insertion in a physiological environment 90 . The nanocomposite of a poly(vinyl acetate) matrix reinforced with rigid cellulose nanocrystals can also be machined in shank-like arrays with ~100-μm 2 cross-section that can be inserted through the pia mater of the cortex of rats without assistive surgical devices 91 . Systematic evaluation of the neuroinflammation response to these mechanically adaptive probes during a 16-week implantation demonstrated that over time, and in contrast to chemically matched but stiff probes (FIG. 5b) , activation of inflammatory cells was nearly completely attenuated and neuronal loss around the soft implant was substantially reduced 92 . Mechanically adaptable materials are also finding promising applications for peripheral nerve interfaces 89, 93 .
Minimizing the electrode footprint. In both the brain 94, 95 and spinal cord 96 , soft neurotechnology strategies also include fibre-like designs and injectable devices (FIGS 3,4) . Ultrasmall carbon fibres with subcellular cross-sections insulated with parylene N and conducting polymer poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS)-coated tips enable chronic recordings of single-unit activity in rats for several weeks 94 . Multi-electrode fibres prepared by thermal drawinga process borrowed from the fibre-optic industry -are a recent and promising design. In one study, microelectrodes (5 μm in diameter) clustered in a single fibre (125 μm in diameter) were used to monitor neural activity at the single-unit level over a period of 2 months 95 . The fibres were prepared with insulating poly(phenylsulfone) or poly(etherimide) and conductive tin. In both examples, fibres remained intact in the brains of rats or mice for weeks of implantation, enabling clear recordings over this time range. Compared with multielectrode silicon shanks, the ultra-miniaturized fibres triggered less glial response, blood-brain barrier breach and tissue encapsulation in the vicinity of the probes 95 . Injecting miniaturized and ultra-flexible electronics into brain tissue is another approach to interface the soft tissues in a minimally invasive procedure with reduced FBR (FIG. 3) . A polyimide shank-like probe with very low bending stiffness and a small footprint can be temporarily mounted on a releasable carrier needle, which detaches once injected into the soft neural tissue 87 . Another design proposes a macroporous mesh made of narrow SU8 epoxy branches 97 . The high degree of porosity (~80%) of the implant together with subcellular feature sizes allow for a synthetic implant with extremely small bending stiffness and high malleability. The mesh format unfolds once in vivo into a 3D interface. Such a probe may be either injected through a hollow needle and then deployed in the liquid compartment of the brain (FIG. 3) (that is, the ventricles where the cerebrospinal fluid is produced) 97 or frozen in liquid nitrogen for rapid insertion into the cortex 98 . Cortical tissues carrying the macroporous ultra-flexible implants for several weeks display high biocompatibility as neural tissue invades the macroporous network. This response minimizes the electrode-neuron distance. Combined with a mature cardiovascular technology, the mesh design can also be used to form a stentrode. This novel implant is a combination of a stent, thin electrodes and transmitters injected into a vein via a catheter to travel in the brain through the bloodstream 99 .
Engineering the local mechanical microenvironment.
Engineering of the mechanical (and surely biochemical) microenvironment at the surface of an implant may be needed to further modulate the FBR. It is increasingly appreciated that neurons and glial cells respond to the mechanical properties of their surroundings 23, 100 : neurons prefer softer regions over stiffer regions for growth and branching 101 ; oligodendrocytes have an optimal stiffness of about 700 Pa (Young's modulus) for growth, proliferation, migration and differentiation 35 ; astrocytes and microglia become activated on stiff surfaces 102 ; and microglia migrate to regions that are stiffer (that is, with a Young's modulus >10 kPa) 103 . One obvious approach to pacify cells in contact with an implant seems to be the use of materials with the same bulk modulus as CNS tissue. ▶ As a proof of concept, implantation of (non-electrically functional) soft hydrogel stripes (with an elastic modulus of 100 Pa) caused less FBR than stripes of the same mat erial that were two orders of magnitude stiffer 102 (FIG. 5c) . The slowly accumulating insight into the molecular mechanisms of the mechano sensing 23, [104] [105] [106] will allow drugable, pharmacological targets to be identified in order to better avoid FBR-causing mechanosensitivity of cells in contact with an implant. Slow release of suitable agonists could then be built into the implant surface to mechanically silence the cells in contact with it (that is, pharmacological stealthing of the implant). It is noteworthy that controlled in vivo release of bioactive agents, such as anti-inflammatory drugs 107 and neurotrophic factors, can be integrated into conducting polymer materials 108 . However, the latter are probably most suitable for improving the electro de-neuron electrical interface 109 . The manufacturing of these materials allows integration with compliant carrier substrates and incorporation in gels.
Conducting polymers offer mixed electronic and ionic conductivity, promising improved charge transfer 110 . Several groups have reported on long-term neural interfaces based on conducting polymers, and extending the electrochemical stability of the polymers in vivo is an active topic of research 94, [111] [112] [113] . PEDOT:PSS, which has a Young's modulus on the order of 100 MPa, is softer than standard electrode metals. Conducting polymer-hydrogel coatings hold significant promise as biointegrated interfaces, whereby the conducting polymer efficiently carries charges, and the hydrogel modulates the mechanical properties and may also enhance the drug-carrying capacity of the coatings 109, 114 . In another interesting approach, tissue-engineered electrodes or 'live' electrodes, in which neuronal cells are encapsulated in a soft conducting hydrogel scaffold, are tailored to provide mechanical and biochemical properties that support cell growth and efficient electrochemical interfaces 109 .
Multimodal soft neural implants
Soft neural implants have, for the most part, been prepared with technologies initially developed for the microelectronic and telecommunication industries. In turn, the use of micro-and nanofabrication techniques in the manufacturing of neural implants in basic research has enabled the design of bidirectional interfaces, capable of distributed and local delivery of multiple inputs, such as electricity, light or drugs, and simultaneously monitoring the activity from one or several neurons. Currently, research implants for neuromodulation are primarily used to write into the nervous system using light to stimulate the neural tissues with improved specificity 115, 116 , or a combination of two stimulation modalities (for example, electricity and pharmacology). Microelectrodes for monitoring neural activity are also often included in the multimodal stimulation interfaces. For example, injectable wireless optoelectronic implants embedded in ultrathin polyimide films incorporate independently addressable microscale inorganic light-emitting diodes that are multicoloured and co-located optical, thermal and electrophysiological sensors and actuators 87 (FIG. 3) .
Complemented by a wireless powering platform, sophisticated and miniaturized implants have already communicated with the brain of freely moving mice, delivering light and pharmacology for several weeks 117 . These results demonstrate the good tolerance of the host medium and potential for long-term studies, which are essential for the development and understanding of neurotherapies. This technology has also recently been demonstrated in a bioresorbable format, enabling a range of acute and short-term applications for transient neural monitoring 82, 83 (FIG. 6a) .
All-polymer fibre probes are another emerging approach for multimodal implants. These probes combine fibre-optical stimulation, drug delivery and electrical recording in a diameter of less than 300 μm (REF. 95 ). Stable optical neuromodulation and the adjacent electrical recording of single-unit cortical neural activity have been demonstrated for up to 2 months post-implantation. In addition, controlled fluid infusion through the integrated hollow channels along the fibre allows for the delivery of not only drugs, but also viral vectors, including those used in optogenetics, and cell-selective neurotoxins to neural tissues 95 . Consequently, ultraflexible polymer-based fibre probes appear as a promising biocompatible, multifunctional tool for dynamic optogenetic mapping of neural circuits in freely behaving animals (FIG. 6b) .
Multimodal soft implants also accelerate progress in translational neuroprosthetic research. Electronic dura mater is a soft multifunctional implant prepared with elastomeric materials and designed to reside in the intrathecal space of the CNS 20 (FIG. 6c) . These implants have been used to deliver electrical stimulations over multiple locations of the spinal cord and to administer serotonergic agents that diffuse in the spinal tissue. The concurrent and co-localized electrical and chemical stimulations reactivate the spinal circuits below the injury 118 , which was shown to restore locomotion in paralysed rats. The embedded microfluidic channel provides highly localized delivery of minimally concentrated pharmacological agents. Electrical pulses delivered through the patterned microelectrode array to the underlying neural structures allow the control of the flexion and extension of the hindlimbs of the paralysed rats over the course of several weeks post-implantation 119 .
A bright future for soft neurotechnology Manufacturing soft implants with brain-like materials is not yet possible; nevertheless, simple design rules (for example, based on thin, flexible materials, elastic membranes, miniaturization to cellular and even subcellular dimensions, multiscale 3D formats and colocalization of different types of transducers) now drive the research community to engineer and test soft neural implants with unprecedented biological integration and modalities.
Although the path to clinical translation remains challenging, the soft neurotechnologies reviewed in this article create possibilities for the development of new therapeutic treatments. The exciting results acquired in academic research, as well as the recent successes of companies such as Second Sight or Sapiens, which both engineered advanced implantable neuroprosthetic systems with a flexible neural interface at the heart of the system, have led to public funding (for example, the Brain Initiative in the USA) and unleashed private investment in start-ups developing implantable neuroprosthetic treatments.
Historically, neuroprosthetic treatments have been broadly divided into replacement and restoration strategies. Replacement primarily refers to the field of brain-machine interfaces, whereas restoration mainly focuses on neuromodulation therapies. The lack of biointegration in the neural tissue of today's implantable brain-machine interfaces impedes their vast dissemination into medical applications. As a consequence, neurointegrated implants, enabled in part by a more careful physical matching of the synthetic-biological interface and providing stable recordings of spiking activity for extended durations, would herald a new era for brainmachine interfaces, in which the prospect of restoring independent communication and assistive device control for people with paralysis would become reality. The stable delivery of electrical currents to the nervous system is considerably less challenging than the long-term recording of electrical signals from neural structures. It therefore comes as no surprise that neuromodulation therapies reached clinical fruition more rapidly than brain-machine interface technologies. For example, dopamine precursors and deep-brain stimulation of the basal ganglia circuitry have become common medical practices to alleviate cognitive and motor symptoms associated with Parkinson's disease.
Theoretically, the possibility of directly and precisely targeting specific brain 120 and spinal cord 119 structures with neuromodulation therapies can lead to remarkably more robust interventions. Soft electrode implants will have a pivotal role in enabling this approach. Indeed, chronic neuromodulation of targeted neural structures across and within the brain and spinal cord will require customized soft implants that match, or at least approach, neural tissue compliance, conform to the unique topography of these regions, and are capable of spatial and temporal selectivity. Moreover, the possibility to integrate microfluidic channels to deliver drugs locally creates exciting prospects of modulating neural excitability and boosting neuroplasticity. Local injections induce fewer side effects than systemic administration, which allows higher drug concentrations and thus more potent effects 20 . Many clinically approved compounds could be used in these applications.
The historical distinction between replacement and restoration strategies is becoming vague and ambiguous. The marriage of brain-machine interface technologies with neuromodulation therapies is occurring at a fast pace. Bidirectional implanted neuroprostheses combining recording and stimulating capabilities offer a unique opportunity to incorporate neural signals into closed-loop stimulation algorithms. The user then directly triggers and modulates the features of the therapy. For example, a quadriplegic person regained cortical control over isolated finger movements using a brain-controlled stimulation of hand muscles 2 . This approach 121 to neuroprosthetic designs is already supported in various research programs. For example, the aim of the ElectRx program is to develop intelligent pacemakers that personalize neuromodulation therapies through the closed-loop control of stimulation parameters. Next-generation implants with bidirectional and multimodal capabilities will have a central role in the success of these programs.
In summary, we are entering the era of personalized neuroprosthetics 122 . Because of the central role of the synthetic-biological interface, it is critical that materials scientists and engineers effectively design implant materials and structures that create an adequate biological and mechanical response with the soft neural tissue. We have gathered the first elements indicating that implant softness is essential to long-term use. It is an exciting time for materials scientists and engineers to discover how to further tailor implantable neuroprostheses and endow individuals suffering from traumatic or neurological disorders with personalized and life-changing therapeutic treatments.
